Tianjin Pharmaceutical Industry: Injectable Methylprednisolone Sodium Succinate obtained a registration certificate from the Ministry of Health of the Dominican Republic.

On the evening of April 30th, Jin Medicine Industry announced that its subsidiary Jin Medicine Heping Injection Methylprednisolone Sodium Succinate has obtained a registration certificate from the Ministry of Health of the Dominican Republic, marking that the product can be manufactured and sold in the Dominican Republic market. Injection Methylprednisolone Sodium Succinate is a corticosteroid drug mainly used for anti-inflammatory treatment, immunosuppressive treatment, treatment of blood disorders and tumors, shock treatment, etc.